Cwa Asset Management Group, LLC Abbott Laboratories Transaction History

Cwa Asset Management Group, LLC

$1.85 Billion
Q3 2024

A detailed history of Cwa Asset Management Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 9,159 shares of ABT stock, worth $1.08 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,159

Previous 10,739 14.71%

Holding current value

$1.08 Million

Previous $1.22 Million 14.43%

% of portfolio

0.06%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $158,110 - $186,645	-1,580 Reduced 14.71%	9,159 $1.04 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $24,203 - $26,732	221 Added 2.1%	10,739 $1.22 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $459,788 - $562,819	5,098 Added 94.06%	10,518 $1.16 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $17,481 - $20,975	183 Added 3.49%	5,420 $524,000
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $57,948 - $64,566	575 Added 12.33%	5,237 $570,000
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $49,786 - $58,601	-514 Reduced 9.93%	4,662 $472,000
Q4 2022 Jan 09, 2023	BUY	$95.06 - $111.52 $73,006 - $85,647	768 Added 17.42%	5,176 $0
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $60,475 - $70,018	625 Added 16.52%	4,408 $427,000
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $65,222 - $78,833	-639 Reduced 14.45%	3,783 $411,000
Q1 2022 Apr 21, 2022	BUY	$114.02 - $139.04 $32,837 - $40,043	288 Added 6.97%	4,422 $523,000
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $88,727 - $108,641	768 Added 22.82%	4,134 $582,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $52,147 - $57,689	447 Added 15.31%	3,366 $398,000
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $65,907 - $77,582	-623 Reduced 17.59%	2,919 $342,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.03%	3,542 $424,000
Q4 2020 Feb 23, 2021	BUY	$105.0 - $114.42 $10,500 - $11,442	100 Added 2.91%	3,541 $388,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $72,240 - $78,720	-688 Reduced 16.66%	3,441 $377,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $31,249 - $37,949	341 Added 9.0%	4,129 $449,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1,607 - $2,058	21 Added 0.56%	3,788 $346,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $84,304 - $123,276	1,342 Added 55.34%	3,767 $297,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $190,386 - $211,945	2,425 New	2,425 $211,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $273,457 - $301,815	-4,750 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $728,977 - $824,197	-12,955 Reduced 73.17%	4,750 $285,000
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $52,069 - $55,745	970 Added 5.8%	17,705 $1.01 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $10,140 - $11,318	-211 Reduced 1.25%	16,735 $893,000
Q2 2017 Aug 10, 2017	BUY	N/A	16,946	16,946 $824,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.

Account

Cwa Asset Management Group, LLC Abbott Laboratories Transaction History